Enlivex Therapeutics Ltd.
ENLV
$1.10
$0.065.77%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 23.50M | 24.51M | 25.94M | 23.44M | 27.32M |
| Total Receivables | 1.42M | 1.40M | 1.26M | 3.70M | 229.00K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 884.00K | 979.00K | 1.14M | 896.00K | 1.11M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 198.00K | 228.00K | 228.00K | 342.00K | 5.11M |
| Total Current Assets | 25.99M | 27.11M | 28.57M | 28.38M | 33.76M |
|
|
|||||
| Total Current Assets | 25.99M | 27.11M | 28.57M | 28.38M | 33.76M |
| Net Property, Plant & Equipment | 1.15M | 1.77M | 2.03M | 2.24M | 2.58M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 541.00K | 915.00K | 1.30M | 429.00K | 487.00K |
| Total Assets | 27.69M | 29.80M | 31.90M | 31.05M | 36.83M |
|
|
|||||
| Total Accounts Payable | 811.00K | 92.00K | 303.00K | 643.00K | 827.00K |
| Total Accrued Expenses | 2.61M | 2.35M | 2.20M | 2.63M | 3.66M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 235.00K | 346.00K | 336.00K | 341.00K | 346.00K |
| Total Finance Division Other Current Liabilities | 142.00K | -- | -- | -- | 1.23M |
| Total Other Current Liabilities | 142.00K | -- | -- | -- | 1.23M |
| Total Current Liabilities | 3.80M | 2.79M | 2.84M | 3.61M | 6.06M |
|
|
|||||
| Total Current Liabilities | 3.80M | 2.79M | 2.84M | 3.61M | 6.06M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 299.00K | 419.00K | 499.00K | 587.00K | 686.00K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 4.10M | 3.21M | 3.34M | 4.20M | 6.75M |
|
|
|||||
| Common Stock & APIC | 149.60M | 147.42M | 146.79M | 141.98M | 141.08M |
| Retained Earnings | -127.11M | -121.93M | -119.33M | -116.23M | -112.09M |
| Treasury Stock & Other | 1.10M | 1.10M | 1.10M | 1.10M | 1.10M |
| Total Common Equity | 23.59M | 26.59M | 28.56M | 26.85M | 30.08M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 23.59M | 26.59M | 28.56M | 26.85M | 30.08M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 23.59M | 26.59M | 28.56M | 26.85M | 30.08M |
|
|
|||||